Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells

Sabine Braun, Michael Gutknecht, Mark-Alexander Schwarzbich, MD, Lothar Kanz, MD, Helmut R Salih, MD, Frank Grünebach, PD, Susanne M Rittig, MD

Blood (2012) 120 (21): 3284.

https://doi.org/10.1182/blood.V120.21.3284.3284

Published: 2012

Journal Articles

Monocyte-Derived Dendritic Cells Induce Functionally Active Regulatory T Cells Upon Exposure to BCR-ABL Tyrosine Kinase Inhibitors.

Michael Gutknecht, Simone Joas, Lisa Güttler, Lothar Kanz, MD, Helmut R Salih, MD, Frank Grünebach, PD, Susanne M Rittig, MD

Blood (2012) 120 (21): 2156.

https://doi.org/10.1182/blood.V120.21.2156.2156

Published: 2012

Journal Articles

Upregulation of Osteoactivin Upon Exposure to Tyrosine Kinase Inhibitors Impairs the T Cell Stimulatory Capacity of Monocyte-Derived Dendritic Cells

Michael Gutknecht, Lisa Güttler, Mark-Alexander Schwarzbich, MD, Julia Salih, Lothar Kanz, MD, Helmut R. Salih, MD, Susanne Malaika Rittig, MD, Frank Grünebach, PD

Blood (2011) 118 (21): 1112.

https://doi.org/10.1182/blood.V118.21.1112.1112

Published: 2011

Journal Articles

The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors

Michael Gutknecht, Mark-Alexander Schwarzbich, Julia Salih, Lothar Kanz, MD, Helmut R. Salih, MD, Susanne M. Schmidt, Frank Grünebach

Blood (2010) 116 (21): 1733.

https://doi.org/10.1182/blood.V116.21.1733.1733

Published: 2010

Journal Articles

Characterization of Gene p306 Expressed in Monocyte Derived Dendritic Cells

Ani ta Bringmann, Ingo Hilgendorf, Silke Appel, Stefanie Held, Karin von Schwarzenberg, Frank Grünebach, Peter Brossart, MD

Blood (2008) 112 (11): 2567.

https://doi.org/10.1182/blood.V112.11.2567.2567

Published: 2008

Journal Articles

Matrilysin (MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells.

Frank Grünebach, Yuko Yokoyama, Susanne M. Schmidt, Stefan Stevanovic, Hans-Georg Rammensee, Lothar Kanz, Peter Brossart

Blood (2007) 110 (11): 1797.

https://doi.org/10.1182/blood.V110.11.1797.1797

Published: 2007

Journal Articles

hDectin-1 Mediates Cross-Presentation of Epitopes Via the Cytosolic Pathway.

Frank Grünebach, Markus M. Weck, Silke Appel, Daniela Werth, Christian Sinzger, Anita Bringmann, Lothar Kanz, Peter Brossart

Blood (2007) 110 (11): 2313.

https://doi.org/10.1182/blood.V110.11.2313.2313

Published: 2007

Journal Articles

Imatinib Inhibits Proteasomal Activity in CML Cells.

Stefanie A.E. Held, Katharina M. Brauer, Thomas Rückrich, Daniela Werth, Karin von Schwarzenberg, Anita Bringmann, Lothar Kanz, Frank Grünebach, Christoph Driessen, Peter Brossart

Blood (2007) 110 (11): 4531.

https://doi.org/10.1182/blood.V110.11.4531.4531

Published: 2007

Journal Articles

TLR ligands differentially affect uptake and presentation of cellular antigens

Markus Michael Weck, Frank Grünebach, Daniela Werth, Christian Sinzger, Anita Bringmann, Peter Brossart

Blood (2007) 109 (9): 3890–3894.

https://doi.org/10.1182/blood-2006-04-015719

Published: 2007

Includes: Supplemental data

Journal Articles

Characterization of Dendritic Cell-Specific Genes p275 and p306.

Ingo Hilgendorf, Daniel Kurz, Anita Bringmann, Lothar Kanz, MD, Frank Grünebach, PhD, Peter Brossart, MD

Blood (2006) 108 (11): 3842.

https://doi.org/10.1182/blood.V108.11.3842.3842

Published: 2006

Journal Articles

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Cristina N. Boß, Frank Grünebach, PhD, Katharina M. Brauer, Toni Weinschenk, PhD, Lothar Kanz, MD, Stefan Stevanovic, PhD, Hans-Georg Rammensee, PhD, Peter Brossart, MD

Blood (2006) 108 (11): 3703.

https://doi.org/10.1182/blood.V108.11.3703.3703

Published: 2006

Journal Articles

Interleukin-10 Severely Impairs TLR Mediated Activation of Antigen Presenting Cells.

Anja Knödler, Anita Bringmann, Markus M. Weck, PhD, Katharina M. Brauer, Lothar Kanz, MD, Frank Grünebach, PhD, Peter Brossart, MD

Blood (2006) 108 (11): 929.

https://doi.org/10.1182/blood.V108.11.929.929

Published: 2006

Journal Articles

Regulation of Dendritic Cell Function by Histone Deacetylase Inhibitors.

Julia Beck, Alessio Nencioni, MD, Frank Grünebach, PhD, Anita Bringmann, Lothar Kanz, MD, Franco Patrone, MD, Alberto Ballestrero, MD, Peter Brossart, MD

Blood (2006) 108 (11): 930.

https://doi.org/10.1182/blood.V108.11.930.930

Published: 2006

Journal Articles

BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells.

Katharina M. Brauer, Daniela Werth, PhD, Karin von Schwarzenberg, Anita Bringmann, Lothar Kanz, MD, Frank Grünebach, PhD, Peter Brossart, MD

Blood (2006) 108 (11): 2202.

https://doi.org/10.1182/blood.V108.11.2202.2202

Published: 2006

Journal Articles

Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation

Alessio Nencioni, Karin Schwarzenberg, Katharina M. Brauer, Susanne M. Schmidt, Alberto Ballestrero, Frank Grünebach, Peter Brossart

Blood (2006) 108 (2): 551–558.

https://doi.org/10.1182/blood-2005-08-3494

Published: 2006

Journal Articles

Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs

Silke Appel, Anita Bringmann, Frank Grünebach, Markus M. Weck, Jürgen Bauer, Peter Brossart

Blood (2006) 107 (8): 3265–3270.

https://doi.org/10.1182/blood-2005-06-2480

Published: 2006

Journal Articles

PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways

Silke Appel, Valdete Mirakaj, Anita Bringmann, Markus M. Weck, Frank Grünebach, Peter Brossart

Blood (2005) 106 (12): 3888–3894.

https://doi.org/10.1182/blood-2004-12-4709

Published: 2005

Journal Articles

hDectin-1 Is Involved in the Uptake of Apoptotic and Infected Cells and Mediates Cross-Presentation of Engulfed Antigens.

Markus M. Weck, PhD, Frank Grünebach, PhD, Daniela Werth, PhD, Lothar Kanz, MD, Christian Sinzger, MD, Peter Brossart, MD

Blood (2005) 106 (11): 3086.

https://doi.org/10.1182/blood.V106.11.3086.3086

Published: 2005

Journal Articles

BCR-ABL Is Not an Immunodominant Antigen in CML.

Frank Grünebach, PhD, Valbona Mirakaj, Martin R. Müller, MD, PhD, Tim Brümmendorf, MD, Peter Brossart, MD

Blood (2005) 106 (11): 2881.

https://doi.org/10.1182/blood.V106.11.2881.2881

Published: 2005

Journal Articles

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro–transcribed MUC1 RNA

Daniela Dörfel, Silke Appel, Frank Grünebach, Markus M. Weck, Martin R. Müller, Annkristin Heine, Peter Brossart

Blood (2005) 105 (8): 3199–3205.

https://doi.org/10.1182/blood-2004-09-3556

Published: 2005

NARROW

Immunosuppressive Drugs up-Regulate the Immunoinhibitory Receptor Osteoactivin On Human Monocyte-Derived Dendritic Cells

Monocyte-Derived Dendritic Cells Induce Functionally Active Regulatory T Cells Upon Exposure to BCR-ABL Tyrosine Kinase Inhibitors.

Upregulation of Osteoactivin Upon Exposure to Tyrosine Kinase Inhibitors Impairs the T Cell Stimulatory Capacity of Monocyte-Derived Dendritic Cells

The Immune-Inhibitory Receptor Osteoactivin Is up-Regulated In Monocyte-Derived Dendritic Cells Upon Exposure to Tyrosine Kinase Inhibitors

Characterization of Gene p306 Expressed in Monocyte Derived Dendritic Cells

Matrilysin (MMP-7) Is a Novel Broadly Expressed Tumor Antigen Recognized by Antigen-Specific T Cells.

hDectin-1 Mediates Cross-Presentation of Epitopes Via the Cytosolic Pathway.

Imatinib Inhibits Proteasomal Activity in CML Cells.

TLR ligands differentially affect uptake and presentation of cellular antigens

Characterization of Dendritic Cell-Specific Genes p275 and p306.

Identification and Characterization of T Cell Epitopes Deduced from RGS5, a Novel Broadly Expressed Tumor Antigen.

Interleukin-10 Severely Impairs TLR Mediated Activation of Antigen Presenting Cells.

Regulation of Dendritic Cell Function by Histone Deacetylase Inhibitors.

BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells.

Proteasome inhibitor bortezomib modulates TLR4-induced dendritic cell activation

Epithelial-specific transcription factor ESE-3 is involved in the development of monocyte-derived DCs

PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways

hDectin-1 Is Involved in the Uptake of Apoptotic and Infected Cells and Mediates Cross-Presentation of Engulfed Antigens.

BCR-ABL Is Not an Immunodominant Antigen in CML.

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro–transcribed MUC1 RNA

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only